Allegheny Financial Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $33.8K | Hold |
|
|||||
|
2025
Q2 | $18.1K | Hold |
|
|||||
|
2025
Q1 | $9.03K | Hold |
|
|||||
|
2024
Q4 | $10.1K | Hold |
|
|||||
|
2024
Q3 | $18.1K | Hold |
|
|||||
|
2024
Q2 | $19.9K | Hold |
|
|||||
|
2024
Q1 | $29.6K | Hold |
|
|||||
|
2023
Q4 | $21.8K | Hold |
|
|||||
|
2023
Q3 | $23.6K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $30K | Hold |
|
|||||
|
2022
Q4 | $23.4K | Hold |
|
|||||
|
2022
Q3 | $22K | Hold |
|
|||||
|
2022
Q2 | $32K | Hold |
|
|||||
|
2022
Q1 | $31K | Hold |
|
|||||
|
2021
Q4 | $49K | Hold |
|
|||||
|
2021
Q3 | $50K | Hold |
|
|||||
|
2021
Q2 | $57K | Hold |
|
|||||
|
2021
Q1 | $47K | Hold |
|
|||||
|
2020
Q4 | $35K | Buy |
|